Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Jinping Wan, Tiegen Xiong, Jianian Hu, Hai Xiao
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Clinical and laboratory features in anti-NF155 autoimmune nodopathy
10.1212/nxi.0000000000001098. · 2021
European academy of neurology/peripheral nerve society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision
10.1111/ene.14959 · 2021
Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy
10.1002/ana.23794 · 2013
Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy
10.1212/wnl.0000000000002418 · 2016
Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy
10.1093/brain/aww189 · 2016
Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy
10.1093/brain/awx124 · 2017
Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia
10.1093/brain/awv054 · 2015
Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis
10.1371/journal.pone.0281156 · 2023
Chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey
10.3389/fneur.2018.00997 · 2018
Contactin-1 is a novel target antigen in membranous nephropathy associated with chronic inflammatory demyelinating polyneuropathy
10.1016/j.kint.2021.08.014 · 2021
Anti-contactin 1 antibody-associated membranous nephropathy in chronic inflammatory demyelinating polyneuropathy with several autoantibodies
10.2169/internalmedicine.2126-23 · 2024
Neuro-renal syndrome related to anti-contactin-1 antibodies
10.1002/mus.26392 · 2019
Characteristics of anti-Contactin1 antibody-associated autoimmune Nodopathies with concomitant membranous nephropathy
10.3389/fimmu.2021.759187 · 2021
Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study
10.1007/s00415-023-11759-2 · 2023
Autoimmune nodopathies, an emerging diagnostic category
10.1097/wco.0000000000001107 · 2022
Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort
10.1136/jnnp-2023-331378 · 2023
CIDP-like autoimmune nodopathy complicated with focal segmental glomerulosclerosis: a case study and literature review
10.1007/s00415-022-11369-4 · 2023
Proteinuria is a key to suspect autoimmune nodopathies
10.1111/ene.16406 · 2024
Case report: pediatric age onset CNTN1 antibody-associated neuropathy with nephropathy and literature review
10.3389/fimmu.2025.1549363 · 2025
CIDP/autoimmune nodopathies with nephropathy: a case series study
10.1002/acn3.51754 · 2023
Chronic inflammatory demyelinating polyneuropathy and concurrent membranous nephropathy associated with anti-Contactin-1 autoantibodies: a rare case report with a review of the literature
10.7759/cureus.83975 · 2025
2019 European league against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus
10.1136/annrheumdis-2018-214819 · 2019
An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management
10.7759/cureus.30330 · 2022
No additional external references are available.